UNITED STATES
 SECURITIES AND EXCHANGE COMMISSION
 Washington, DC  20549
 
 Form 10-Q
 
 
 (Mark one)
 x
Quarterly Report under Section 13 or 15(d) of the Securities Exchange Act of 1934For the quarterly period ended June 30, 2016o
Transition Report under Section 13 or 15(d) of the Securities Exchange Act of 1934For the transition period from ______________ to _____________
 
 
 Commission File Number: 000-54770
 
 
 MCPI, Inc.
 (Exact name of registrant as specified in its charter)
 
 Nevada
45-0704149(State of incorporation)
(IRS Employer ID Number)
 
 454 SW Coast Highway, Newport, OR 97365
 (Address of principal executive offices)
 
 (214) 666-8364
 (Issuer’s telephone number)
 Check whether the issuer (1) filed all reports required to be filed by Section 13 or 15(d) of the Exchange Act during the past 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  YES  x  NO  o
 
 Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). YES  x  NO  o
 
 Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company.  See the definitions of “large accelerated filer”, “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check one):
 
 Large accelerated filer o
Accelerated filer oNon-accelerated filer o
Smaller reporting company x
 
 Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act): YES  o  NO  x
  August 1, 2016: 50,220,000 shares of common stock, par value $0.001
  MCPI, Inc.
 
 Form 10-Q for the Quarter ended June 30, 2016
 
 Table of Contents
 PagePart I - Financial InformationItem 1 - Financial Statements
3Item 2 - Management's Discussion and Analysis of Financial Condition and Results of Operations
13Item 3 - Quantitative and Qualitative Disclosures About Market Risk
15Item 4 - Controls and Procedures
15Part II - Other InformationItem 1 - Legal Proceedings
15Item 1A - Risk Factors
15Item 2 - Sales of Unregistered Equity Securities and Use of Proceeds
15Item 3 - Defaults Upon Senior Securities
15Item 4 - Mine Safety Disclosures
15Item 5 - Other Information
15Item 6 - Exhibits
16Signatures
16


2
 
 Part I - Financial Information
 
 Item 1 - Financial Statements
 
 MCPI, Inc.
 Consolidated Balance Sheets
 June 30, 2016 and December 31, 2015
 
 
 (Unaudited)


(Audited)June 30,


December 31,2016


2015ASSETSCurrent AssetsCash and cash equivalents

$
—


$
—Total Current Assets


—



—Total Assets

$
—


$
—LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)Current LiabilitiesAccounts payableThird parties

$
27,440


$
20,947Accrued expensesRelated parties


59,846



59,846Accrued interest payableRelated parties


19,475



81,816Note payable to stockholder


774,151



607,314Total Liabilities


880,912



769,923Commitments and ContingenciesStockholders' Equity (Deficit)Preferred stock - $0.001 par value25,000,000 shares authorized.None issued and outstanding.


—



—Common stock - $0.001 par value.500,000,000 shares authorized.50,220,000 and 50,170,000 sharesissued and outstanding


50,220



50,220Additional paid-in capital


59,336,620



59,336,620Accumulated deficit


(60,267,752
)


(60,156,763
)Total Stockholders' Equity (Deficit)


(880,912
)


(769,923
)Total Liabilities and Stockholders’ Equity (Deficit)

$
—


$
—
 
 
 
 
 The accompanying notes are an integral part of these consolidated financial statements.
  3
  MCPI, Inc.
 Consolidated Statements of Operations and Comprehensive Loss
 Six and Three months ended June 30, 2016 and 2015
 
 (Unaudited)
 
 
 Six months


Six months


Three months


Three monthsended


ended


ended


endedJune 30,


June 30,


June 30,


June 30,2016


2015


2016


2015Revenues

$
—


$
—


$
—


$
—Cost of Sales


—



—



—



—Gross Profit


—



—



—



—Operating expensesProfessional fees


67,627



328,493



49,896



12,588General and administrative costs


—



211,156



—



86,604Total operating expenses


67,627



539,649



49,896



99,192Loss from operations


(67,627
)


(539,649
)


(49,896
)


(99,192
)Other income (expense)Loss from abandoned grow operation


—



(6,942
)


—



(6,942
)Interest expense on notes payable to stockholder


(43,362
)


(23,152
)


(19,475
)


(14,337
)Loss before provision for income taxes


(110,989
)


(569,743
)


(69,371
)


(120,471
)Provision for income taxes


—



—



—



—Net loss


(110,989
)


(569,743
)


(69,371
)


(120,471
)Other comprehensive income


—



—



—



—Comprehensive loss

$
(110,989
)

$
(569,743
)

$
(69,371
)

$
(120,471
)Loss per weighted-average share of common stock outstanding,computed on net loss basic and fully diluted

$
(0.00
)

$
(0.01
)

$
(0.00
)

$
(0.00
)Weighted-average number of shares of common stock outstanding -basic and fully diluted


50,220,000



50,213,094



50,220,000



50,220,000
 
 
 
 
 The accompanying notes are an integral part of these consolidated financial statements.
  4
  MCPI, Inc.
 Consolidated Statement of Changes in Stockholders’ Equity (Deficit)
 Six months ended June 30, 2016 and
 Year ended December 31, 2015
 
 (Unaudited)
 
 
 AdditionalCommon Stock


paid—in


AccumulatedShares


Amount


capital


Deficit


TotalBalances at January 1, 2015


50,170,000


$
50,170


$
59,021,670


$
(59,418,274
)

$
(346,434
)Issuance of common stock for consulting fees


50,000



50



14,950



—



15,000Contributed capital


—



—



300,000



—



300,000Net loss for the year


—



—



—



(738,489
)


(738,489
)Balances at December 31, 2015


50,220,000



50,220



59,336,620



(60,156,763
)


(769,923
)Net loss for the year


—



—



—



(110,989
)


(110,989
)Balances at June 30, 2016


50,220,000


$
50,220


$
59,336,620


$
(60,267,752
)

$
(880,912
)
 
 
 
 
 The accompanying notes are an integral part of these consolidated financial statements.
  5
  MCPI, Inc.
 Consolidated Statements of Cash Flows
 Six months ended June 30, 2016 and 2015
 
 (Unaudited)
 
 
 Six months


Six monthsended


endedJune 30,


June 30,2016


2015Cash Flows from Operating ActivitiesNet income (loss) for the period

$
(110,989
)

$
(569,743
)Adjustments to reconcile net loss to net cash used in operating activitiesDepreciation and amortization


—



7,711Common stock issued for professional fees


—



15,000Note payable to related party restructuring fees


21,140



—Donated capital


—



300,000(Increase) Decrease inAccounts receivable


—



(93,800
)Other assets


—



(2,711
)Increase (Decrease) inAccounts payable


6,493



41,043Accrued expenses


43,362



(9,060
)Deferred revenues


—



(5,000
)Net cash used in operating activities


(39,994
)


(316,560
)Cash Flows from Investing ActivitiesPurchase of fixed assets in subsequently abandoned grow operation


—



(39,345
)Net cash used in investing activities


—



(39,345
)Cash Flows from Financing ActivitiesCash received from notes payable to stockholders


39,994



368,648Net cash provided by financing activities


39,994



368,648Increase (Decrease) in Cash


—



12,743Cash at beginning of period


—



14,763Cash at end of period

$
—


$
27,506Supplemental Disclosure of Interest and Income Taxes PaidInterest paid during the period

$
—


$
—Income taxes paid during the period

$
—


$
—Supplemental Disclosure of Non-Cash Investing andFinancing Activities

$
—


$
—
 
 
 
 
 The accompanying notes are an integral part of these consolidated financial statements.
  6
  MCPI, Inc.
 Notes to Consolidated Financial Statements
 June 30, 2016 and December 31, 2015
 
 (Unaudited)
 
 
 Note A - Background and Description of Business
 
 MCPI, Inc. (“Company” or “Med-Cannabis Pharma”) was incorporated under the laws of the State of Nevada on February 23, 2011.  The Company was originally incorporated as Southwest China Imports, Inc. on February 23, 2011 in the State of Nevada.  The Company’s initial business plan was to import high-end handmade lace wigs, hairpieces, and other beauty supplies and accessories manufactured overseas into the United States.  In June 2014, the Company changed its name to Med-Cannabis Pharma, Inc. and implemented a new business plan to enter into the retail sale of medical and personal use  marijuana, where allowable.  In October 2015, the Company changed its name to MCPI, Inc.
 
 Effective March 31, 2016, the Company ceased activities in all of its subsidiaries and disposed of Med-Pharma Management, Inc. and High Desert MMJ, Inc.  Prior thereto, the Company’s  subsidiaries were Medical Management Systems, Inc., an Oregon corporation engaged in providing back-office and support services to marijuana dispensaries in the State of Oregon; Med-Pharma Management, Inc., a Washington State corporation which was formed to own, manage or provide back-office and support services to marijuana dispensaries in Washington State; and High Desert MMJ, Inc. an Oregon corporation, which is a 99.0% partner in Emerald Mountain Organics, an Oregon joint venture, formed to facilitate the development and growing of medical marijuana plants for wholesale distribution to licenced dispensaries in the State of Oregon.
 
 As of September 30, 2015, Medical Management Systems, Inc. held a Management Contract for three marijuana dispensaries located in Newport, Bend and Cottage Grove, Oregon; which are owned by a company controlled by a related party.  This Management Contract was terminated by the consent of both parties, effective March 31, 2016.   Med-Pharma only conducted introductory due diligence efforts in the State of Washington and, currently, had abandoned all activities in the State of Washington.  Emerald Mountain Organics had, as of September 30,2015, established an early-phase growing operation and has generated nominal sales.
 
 During the first 10 days of October 2015, the Company’s subsidiary, High Desert MMJ, Inc., learned that the 1.0% minority partner in the Emerald Mountain Organics joint venture had absconded with all of the assets of the joint venture.  Efforts to locate and recover either the individuals representing said 1.0% minority partner or the said absconded assets were unsuccessful.  Accordingly, effective October 10, 2015, High Desert MMJ, Inc. abandoned the Emerald Mountain Organics joint venture and wrote off said investment.  The cumulative start-up losses in the Company’s consolidated financial statements for the Emerald Mountain Organics joint venture, through the date of abandonment were approximately $53,000 and the Company recognized a loss on the stolen assets of approximately $51,000 during the quarter ended December 31, 2015.
 
 On June 1, 2016, the Company entered into a Settlement, General and Mutual Release of Claims and Assignment of Interest Transfer Agreement (Settlement Agreement) with its majority shareholder and a related party.  The Settlement Agreement relates to the Company’s management of three medical marijuana dispensaries (Stores) located in Oregon, which are owned by Bendor Investments, Ltd. (Bendor), whose sole shareholder is Charles Stidham.  The Company owes Mr. Stidham approximately $1,100,000, including accrued interest, as of the date of the Settlement Agreement.
 
 The Company asserted a claim for management fees of approximately $80,000 and reimbursement of monies advanced to support the operations of the Stores totaling approximately $343,000 for the services of the Company’s wholly-owned subsidiary, Medical Management Systems, Inc. (MMS), in managing the Stores.  Bendor disputed this claim.  To resolve the dispute, the parties agreed to forgive the accrued management fees and to offset the approximately $343,000 due from Bendor against the approximately $1,100,000 owed to Mr. Stidham with the Company releasing any and all interests it may have had in the Stores and MMS.  Additionally, the Company agreed to assign a trademark to Mr. Stidham as well as executing a new Note in the principal sum of $752,694.19.
 
 Note B - Preparation of Financial Statements
 
 The Company follows the accrual basis of accounting in accordance with generally accepted accounting principles and has elected a year-end of December 31.
 
 The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.  Actual results could differ from those estimates.
  7
  MCPI, Inc.
 Notes to Consolidated Financial Statements - Continued
 June 30, 2016 and December 31, 2015
 
 (Unaudited)
 
 
 Note B - Preparation of Financial Statements - Continued
 
 Management further acknowledges that it is solely responsible for adopting sound accounting practices, establishing and maintaining a system of internal accounting control and preventing and detecting fraud.  The Company’s system of internal accounting control is designed to assure, among other items, that 1) recorded transactions are valid; 2) valid transactions are recorded; and 3) transactions are recorded in the proper period in a timely manner to produce financial statements which present fairly the financial condition, results of operations and cash flows of the Company for the respective periods being presented.
 
 During interim periods, the Company follows the accounting policies set forth in its annual audited financial statements filed with the U. S. Securities and Exchange Commission on its Annual Report on Form 10-K for the year ended December 31, 2015.  The information presented within these interim financial statements may not include all disclosures required by accounting principles generally accepted in the United States of America and the users of financial information provided for interim periods should refer to the annual financial information and footnotes when reviewing the interim financial results presented herein.
 
 In the opinion of management, the accompanying interim financial statements, prepared in accordance with the U. S.  Securities and Exchange Commission’s instructions for Form 10-Q, are unaudited and contain all material adjustments, consisting only of normal recurring adjustments necessary to present fairly the financial condition, results of operations and cash flows of the Company for the respective interim periods presented.  The current period results of operations are not necessarily indicative of results which ultimately will be reported for the full fiscal year ending December 31, 2016.
 
 For segment reporting purposes, the Company operated in only one industry segment during the periods represented in the accompanying financial statements and makes all operating decisions and allocates resources based on the best benefit to the Company as a whole.
 
 The accompanying consolidated financial statements, as of and for the periods ended June 30, 2016 and 2015, respectively, contain the accounts of MCPI, Inc.; its wholly-owned subsidiaries, Medical Management Systems, Inc., Med-Pharma Management, Inc., High Desert MMJ, Inc.; and it’s majority-owned joint venture, Emerald Mountain Organics.  All significant intercompany transactions have been eliminated.  The consolidated entities are collectively referred to as “Company”.
 
 Note C - Going Concern Uncertainty
 
 The Company was in the initial phases of providing back-office and support services to marijuana dispensaries and participates in a marijuana development and growing operation, all located in the State of Oregon.  The dispensary operations under management by Medical Management Systems, Inc. began generating positive cash flows from operations during the 4th quarter of 2015.  However, management terminated the Medical Management Systems, Inc. Management Agreement on March 31, 2016 and wrote off all management fees (and deferred revenues) through that date.  Further, the Company liquidated its Med-Pharma Management, Inc. and High Desert MMJ, Inc. subsidiaries as of March 31, 2016.  All other efforts started by the Company and/or its subsidiaries in prior periods were either unsuccessful or abandoned.  There is no assurance that the Company will be able to successful in the implementation or operation of its current business plan.
 
 The Company has limited operating history, limited cash on hand, no operating assets and has a business plan with inherent risk.  Because of these factors, the Company’s auditors have issued an audit opinion on the Company’s financial statements which includes a statement describing our going concern status.  This means, in the auditor’s opinion, substantial doubt about our ability to continue as a going concern exists at the date of their opinion.
 
 Because of the Company's lack of operating assets, the Company’s continuance may become fully dependent upon either future sales of securities and/or advances or loans from significant stockholders or corporate officers to provide sufficient working capital to preserve the integrity of the corporate entity during the development phase.
 
 The Company's continued existence is dependent upon its ability to implement its business plan, generate sufficient cash flows from operations to support its daily operations, and provide sufficient resources to retire existing liabilities and obligations on a timely basis.  The Company faces considerable risk in it’s business plan and a potential shortfall of funding due to our uncertainty to raise adequate capital in the equity securities market.
  8
  MCPI, Inc.
 Notes to Consolidated Financial Statements - Continued
 June 30, 2016 and December 31, 2015
 
 (Unaudited)
 
 
 Note C - Going Concern Uncertainty - Continued
 
 The Company is dependent upon existing cash balances to support its day-to-day operations.  In the event that working capital sufficient to maintain the corporate entity and implement our business plan is not available, the Company’s existing controlling stockholders intend to maintain the corporate status of the Company and provide all necessary working capital support on the Company's behalf.  However, no formal commitments or arrangements to advance or loan funds to the Company or repay any such advances or loans exist.  There is no legal obligation for either management or existing controlling stockholders to provide additional future funding. Further, the Company is at the mercy of future economic trends and business operations for the Company’s existing controlling stockholders to have the resources available to support the Company.
 
 The Company anticipates offering future sales of equity securities.  However, there is no assurance that the Company will be able to obtain additional funding through the sales of additional equity securities or, that such funding, if available, will be obtained on terms favorable to or affordable by the Company.
 
 The Company’s Articles of Incorporation authorizes the issuance of up to 25,000,000 million shares of preferred stock and 500,000,000 shares of common stock.  The Company’s ability to issue preferred stock may limit the Company’s ability to obtain debt or equity financing as well as impede the implementation of the Company’s business plan.  The Company’s ability to issue these authorized but unissued securities may also negatively impact our ability to raise additional capital through the sale of our debt or equity securities.
 
 In such a restricted cash flow scenario, the Company would be unable to complete its business plan steps, and would, instead, delay all cash intensive activities.  Without necessary cash flow, the Company may become dormant during the next twelve months, or until such time as necessary funds could be raised in the equity securities market.
 
 While the Company is of the opinion that good faith estimates of the Company’s ability to secure additional capital in the future to reach its goals have been made, there is no guarantee that the Company will receive sufficient funding to sustain operations or implement any future business plan steps.
 
 
 Note D - Summary of Significant Accounting Policies
 
 1.
Cash and cash equivalents
 
 The Company considers all cash on hand and in banks, certificates of deposit and other highly-liquid investments with maturities of three months or less, when purchased, to be cash and cash equivalents.
 
 2.
Organization costs
 
 The Company has adopted the provisions of provisions required by the Start-Up Activities topic of the FASB Accounting Standards Codification whereby all costs incurred with the incorporation and reorganization, post-bankruptcy, of the Company were charged to operations as incurred.
 
 3.
Revenue recognition
 
 Revenue is recognized by the Company at the point at which a transaction is delivered or services are provided to a consumer at a fixed price, collection is reasonably assured, the Company has no remaining performance obligations and no right of return by the purchaser exists.
 
 4.
Income taxes
 
 The Company files income tax returns in the United States of America and various states, as appropriate and applicable.  The Company is no longer subject to U.S. federal, state and local, as applicable, income tax examinations by regulatory taxing authorities for any period prior to January 1, 2011.
 
 The Company uses the asset and liability method of accounting for income taxes.  At June 30, 2016 and December 31, 2015, respectively, the deferred tax asset and deferred tax liability accounts, as recorded when material to the financial statements, are entirely the result of temporary differences.  Temporary differences generally represent differences in the recognition of assets and liabilities for tax and financial reporting purposes, primarily accumulated depreciation and amortization, allowance for doubtful accounts and vacation accruals.
  9
  MCPI, Inc.
 Notes to Consolidated Financial Statements - Continued
 June 30, 2016 and December 31, 2015
 
 (Unaudited)
 
 
 Note D - Summary of Significant Accounting Policies - continued
 
 4.           Income taxes - continued
 
 The Company has adopted the provisions required by the Income Taxes topic of the FASB Accounting Standards Codification.  The Codification Topic requires the recognition of potential liabilities as a result of management’s acceptance of potentially uncertain positions for income tax treatment on a “more-likely-than-not” probability of an assessment upon examination by a respective taxing authority.  As a result of the implementation of Codification’s Income Tax Topic, the Company did not incur any liability for unrecognized tax benefits.
 
 5.           Income (Loss) per share
 
 Basic earnings (loss) per share is computed by dividing the net income (loss) available to common stockholders by the weighted-average number of common shares outstanding during the respective period presented in our accompanying financial statements.
 
 Fully diluted earnings (loss) per share is computed similar to basic income (loss) per share except that the denominator is increased to include the number of common stock equivalents (primarily outstanding options and warrants).
 
 Common stock equivalents represent the dilutive effect of the assumed exercise of the outstanding stock options and warrants, using the treasury stock method, at either the beginning of the respective period presented or the date of issuance, whichever is later, and only if the common stock equivalents are considered dilutive based upon the Company’s net income (loss) position at the calculation date.
 
 As of June 30, 2016 and 2015, respectively, the Company does not have any outstanding items which could be deemed to be dilutive.
 
 6.           New and Pending Accounting Pronouncements
 
 The Company is of the opinion that any and all other pending accounting pronouncements, either in the adoption phase or not yet required to be adopted, will not have a significant impact on the Company's financial position or results of operations.
 
 Note E - Fair Value of Financial Instruments
 
 The carrying amount of cash, accounts receivable, accounts payable and notes payable, as applicable, approximates fair value due to the short term nature of these items and/or the current interest rates payable in relation to current market conditions.
 
 Interest rate risk is the risk that the Company’s earnings are subject to fluctuations in interest rates on either investments or on debt and is fully dependent upon the volatility of these rates.  The Company does not use derivative instruments to moderate its exposure to interest rate risk, if any.
 
 Financial risk is the risk that the Company’s earnings are subject to fluctuations in interest rates or foreign exchange rates and are fully dependent upon the volatility of these rates.  The Company does not use derivative instruments to moderate its exposure to financial risk, if any.
 
 Note F - Notes Payable to Stockholders
 
 On July 28, 2014, the Company entered into a $500,000 Line of Credit note payable with South Beach Live, Ltd. (South Beach), a Company stockholder and an entity related to a significant Company stockholder, to provide funds necessary to support the corporate entity and provide working capital to pursue business combination or acquisition opportunities.  This note bore interest at 10.0% and matured in July 2015.  This note replaced a non-interest bearing shareholder note payable to a former controlling stockholder that was assumed during a 2014 change in control transaction.  During the twelve months ended December 31, 2014, the Company recognized an aggregate $4,973 as additional paid-in capital for the economic event related to the non-interest bearing feature on the assumed note payable through its retirement.
 
 On September 30, 2015, the Company executed a replacement Promissory Note with the principal stockholder of South Beach Live, Ltd. in the amount of $927,000, bearing interest at 12.0% and payable in monthly installments of approximately $13,300, including accrued interest with a final maturity and balloon payment due on October 31, 2016.
  10
  MCPI, Inc.
 Notes to Consolidated Financial Statements - Continued
 June 30, 2016 and December 31, 2015
 
 (Unaudited)
 
 
 Note F - Notes Payable to Stockholders - Continued
 
 Through June 30, 2016 and December 31, 2015, respectively, an aggregate of approximately $774,151 and $607,314, inclusive of the effect of the June 1, 2016 Settlement Agreement, as the lender continues to advance funds to support the Company’s working capital needs.  The Company is delinquent in making the required monthly installment payments.
 
 Note G - Income Taxes
 
 The components of income tax (benefit) expense for the each of the six months ended June 30, 2016 and 2015, respectively, are as follows:
 
 Six months


Six monthsended


endedJune 30,


June 30,2016


2015Federal:Current

$
—


$
—Deferred


—



——



—State:Current


—



—Deferred


—



——



—Total

$
—


$
—
 
 As of June 30, 2016, the Company had aggregate net operating loss carryforward(s) to offset future taxable income of approximately $1,210,000.   The amount and availability of any net operating loss carryforward(s) will be subject to the limitations set forth in the Internal Revenue Code.  Such factors as the number of shares ultimately issued within a three year look-back period; whether there is a deemed more than 50 percent change in control; the applicable long-term tax exempt bond rate; continuity of historical business; and subsequent income of the Company all enter into the annual computation of allowable annual utilization of any net operating loss carryforward(s).
 
 The Company's income tax (benefit) expense for the each of the six months ended June 30, 2016 and 2015, respectively, are as follows:
 
 Six months


Six monthsended


endedJune 30,


June 30,2016


2015Statutory rate applied to income before income taxes

$
(32,600
)

$
(193,700
)Increase (decrease) in income taxes resulting from:State income taxes


—



—Other, including reserve for deferred tax assetand application of net operating loss carryforward(s)


32,600



193,700Income tax expense

$
—


$
—
 
 Temporary differences, consisting primarily of the prospective usage of net operating loss carryforwards give rise to deferred tax assets and liabilities as of June 30, 2016 and December 31, 2015, respectively:
 
 June 30,


December 31,2016


2015Deferred tax assetsNet operating loss carryforwards

$
417,600


$
385,000Less valuation allowance


(417,600
)


(385,000
)Net Deferred Tax Asset

$
—


$
—
 
 During the six months ended June 30, 2016 and for the year ended December 31, 2015, respectively, the valuation allowance against the deferred tax asset increased by approximately $32,600 and $251,000.
  11
  MCPI, Inc.
 Notes to Consolidated Financial Statements - Continued
 June 30, 2016 and December 31, 2015
 
 (Unaudited)
 
 
 Note H - Common Stock Transactions
 
 On March 23, 2016, the Company filed an amendment to its Articles of Incorporation stating “After giving effect to a ten for one reverse split, Article III is amended to read as follows: The total number of shares of all classes of stock which the Corporation shall have the authority to issue is five hundred twenty five million (525,000,000) shares, of which five hundred million (500,000,000) shares, par value $0.001 per share, shall be designated as “Common Stock” and twenty five million (25,000,000) shares, par value $0.001 per share, shall be designated as “Preferred Stock.”  The effect of this action is reflected in the accompanying financial statements as of the first day of the first period presented.
 
 On January 15, 2015, the Company issued an aggregate of 50,000 shares for consulting services related to the provision of back-office and other management support services to marijuana dispensaries located in the State of Oregon.  This stock was valued at $0.30 per share, which approximated the closing price on date of the issuance.
 
 During the period ended March 31, 2015, South Beach Live, Inc., a corporation controlled by a majority shareholder of the Company, transferred 1,000,000 shares of its holdings in the Company’s common stock to consultants for ongoing services associated with marketing strategies.  South Beach Live, Inc. is a related party and does not expect to be repaid for this transaction which was valued at approximately $300,000 and recorded as professional fees and contributed capital on the books of the Company.
 
 Note I - Preferred Stock
 
 The Company is authorized to issue up to 25,000,000 shares of preferred stock, $0.001 par value.  As of December 31, 2015, there are no shares of preferred stock issued and outstanding.
 
 Note J - Subsequent Events
 
 On February 29, 2016, the Company filed a Definitive Information Statement on Schedule 14C with the Securities and Exchange Commission noting a pending 1 for 10 reverse split of the Company’s issued and outstanding common stock; as approved by the Company’s Board of Directors, and a concurrent amendment to the Company’s Articles of Incorporation setting the authorized capital of the Company from the authorized, as adjusted, 25,000,000 post-split shares of common stock to 500,000,000 shares of $0.001 par value common stock and the authorized, as adjusted, 250,000 post-split shares of preferred stock to 25,000,000 shares of $0001 par value preferred stock.  This action is anticipated to be completed during the 3rd quarter of Calendar 2016.
 
 Management has evaluated all other activity of the Company through the issue date of the financial statements and concluded that no subsequent events have occurred that would require recognition in the accompanying financial statements or disclosure in the Notes to Consolidated Financial Statements.
  12
  Item 2 - Management’s Discussion and Analysis of Financial Condition and Results of Operations
 
 (1) Caution Regarding Forward-Looking Information
 
 Certain statements contained in this annual filing, including, without limitation, statements containing the words "believes", "anticipates", "expects" and words of similar import, constitute forward-looking statements. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company, or industry results, to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements.
 
 Such factors include, among others, the following: international, national and local general economic and market conditions: demographic changes; the ability of the Company to sustain, manage or forecast its growth; the ability of the Company to successfully make and integrate acquisitions; existing government regulations and changes in, or the failure to comply with, government regulations; adverse publicity; competition; fluctuations and difficulty in forecasting operating results; changes in business strategy or development plans; business  disruptions; the ability to attract and retain qualified personnel; and other factors referenced in this and previous filings.
 
 Given these uncertainties, readers of this Form 10-Q and investors are cautioned not to place undue reliance on such forward-looking statements. The Company disclaims any obligation to update any such factors or to publicly announce the result of any revisions to any of the forward-looking statements contained herein to reflect future events or developments.
 
 (2) General
 
 The Company was originally incorporated as Southwest China Imports, Inc. on February 23, 2011 in the State of Nevada.  The Company’s initial business plan was to import high-end handmade lace wigs, hairpieces, and other beauty supplies and accessories manufactured overseas into the United States.
 
 In June 2014, the Company changed its name to Med-Cannabis Pharma, Inc. and implemented a new business plan to enter into the retail sale of medical and personal use  marijuana, where allowable.  In October 2015, the Company changed its name to MCPI, Inc.
 
 Effective March 31, 2016, the Company ceased activities in all of its subsidiaries and disposed of Med-Pharma Management, Inc. and High Desert MMJ, Inc.  Prior thereto, the Company’s  subsidiaries were Medical Management Systems, Inc., an Oregon corporation engaged in providing back-office and support services to marijuana dispensaries in the State of Oregon; Med-Pharma Management, Inc., a Washington State corporation which was formed to own, manage or provide back-office and support services to marijuana dispensaries in Washington State; and High Desert MMJ, Inc. an Oregon corporation, which is a 99.0% partner in Emerald Mountain Organics, an Oregon joint venture, formed to facilitate the development and growing of medical marijuana plants for wholesale distribution to licenced dispensaries in the State of Oregon.
 
 As of September 30, 2015, Medical Management Systems, Inc. held a Management Contract for three marijuana dispensaries located in Newport, Bend and Cottage Grove, Oregon; which are owned by a company controlled by a related party.  This Management Contract was terminated by the consent of both parties, effective March 31, 2016.   Med-Pharma only conducted introductory due diligence efforts in the State of Washington and, currently, has abandoned all activities in the State of Washington.  Emerald Mountain Organics had, as of September 30,2015, established an early-phase growing operation and has generated nominal sales.
 
 During the first 10 days of October 2015, the Company’s subsidiary, High Desert MMJ, Inc., learned that the 1.0% minority partner in the Emerald Mountain Organics joint venture had absconded with all of the assets of the joint venture.  Efforts to locate and recover either the individuals representing said 1.0% minority partner or the said absconded assets were unsuccessful.  Accordingly, effective October 10, 2015, High Desert MMJ, Inc. abandoned the Emerald Mountain Organics joint venture and wrote off said investment.  The cumulative start-up losses in the Company’s consolidated financial statements for the Emerald Mountain Organics joint venture, through the date of abandonment were approximately $53,000 and the Company recognized a loss on the stolen assets of approximately $51,000 during the quarter ended December 31, 2015.
 
 On June 1, 2016, the Company entered into a Settlement, General and Mutual Release of Claims and Assignment of Interest Transfer Agreement (Settlement Agreement) with its majority shareholder and a related party.  The Settlement Agreement relates to the Company’s management of three medical marijuana dispensaries (Stores) located in Oregon, which are owned by Bendor Investments, Ltd. (Bendor), whose sole shareholder is Charles Stidham.  The Company owes Mr. Stidham approximately $1,100,000, including accrued interest, as of the date of the Settlement Agreement.
 
 The Company asserted a claim for management fees of approximately $80,000 and reimbursement of monies advanced to support the operations of the Stores totaling approximately $343,000 for the services of the Company’s wholly-owned subsidiary, Medical Management Systems, Inc. (MMS), in managing the Stores.  Bendor disputed this claim.  To resolve the dispute, the parties agreed to forgive the accrued management fees and to offset the approximately $343,000 due from Bendor against the approximately $1,100,000 owed to Mr. Stidham with the Company releasing any and all interests it may have had in the Stores and MMS.  Additionally, the Company agreed to assign a trademark to Mr. Stidham as well as executing a new Note in the principal sum of $752,694.19.  The effect of the June 1, 2016 Settlement Agreement , due to the timing of this release of these amended financial statements and this transaction, is reflected in the accompanying consolidated financial statements.
 
 As of March 31, 2016, the Company had ceased all operations related to the marijuana industry and had liquidated all subsidiaries.
  13
  (3) Results of Operations
 
 The Company recognized no revenues during either of the six or three month periods ended June 30, 2016 and 2015, respectively.  Concurrent with the March 31, 2016 termination of the Management Contract held by Medical Management Systems, Inc., the Company wrote off the approximate $80,000 in accrued management fees and the corresponding deferred revenues of equal amount.  The Company never recognized any revenues from said Management Contract as the ultimate receipt of payment, if any, was always in doubt in the opinion of the Company’s management.
 
 The Company incurred general operating expenses of approximately $67,600 and $540,000  during each of the respective six month periods ended June 30, 2016 and 2015.  These expenses were predominately related to legal and professional fees, efforts to implement the Company’s business plan, maintenance of the corporate entity and compliance with the periodic reporting requirements of being a publicly-owned company.  Expenditure levels are anticipated to fluctuate depending on the Company’s activities related to its stated business plan.
 
 Loss per share for each of the six month periods ended June 30, 2016 and 2015, respectively, were $0.00 and $(0.01), based on the weighted-average shares issued and outstanding during each period.
 
 The Company does not expect to generate any meaningful revenue or incur operating expenses for purposes other than fulfilling the objectives of the Company’s business plan, as previously stated, and the obligations of being a reporting company under the Securities Exchange Act of 1934.
 
 (4) Plan of Business
 
 The Company is seeking other business opportunities at this time; however, as of the release date of this report, the Company has no definitive agreement or other arrangement related to any potential business transaction.
 
 (5) Liquidity and Capital Resources
 
 At June 30, 2016 and December 31, 2015, respectively, the Company had working capital of approximately $(881,000) and $(770,000), respectively; inclusive of all related party accounts receivable, accrued expenses and line-of-credit notes payable.
 
 It is the belief of management and significant stockholders that they will provide sufficient working capital necessary to support and preserve the integrity of the corporate entity.   However, there is no legal obligation for either management or significant stockholders to provide additional future funding.  Further, the Company is at the mercy of future economic trends and business operations for the Company’s majority stockholder to have the resources available to support the Company.  Should this pledge fail to provide financing, the Company has not identified any alternative sources.  Consequently, there is substantial doubt about the Company's ability to continue as a going concern.
 
 The Company's need for working capital may change dramatically as a result of any future business transaction.  There can be no assurance that the Company will identify and/or enter into any business transaction in the future.  Further, there can be no assurance that the Company would be successful in consummating any acquisition on favorable terms or that it will be able to profitably manage the business, product, technology or company it acquires.
 
 The Company has no current plans, proposals, arrangements or understandings with respect to the sale or issuance of additional securities prior to the location of a potential business transaction.  Accordingly, there can be no assurance that sufficient funds will be available to the Company to allow it to cover the expenses related to such activities.
 
 Regardless of whether the Company’s cash assets prove to be inadequate to meet the Company’s operational needs, the Company might seek to compensate providers of services by issuances of stock in lieu of cash.
 
 (6) Critical Accounting Policies
 
 Our financial statements and related public financial information are based on the application of accounting principles generally accepted in the United States (“GAAP”).  GAAP requires the use of estimates; assumptions, judgments and subjective interpretations of accounting principles that have an impact on the assets, liabilities, revenue and expense amounts reported.  These estimates can also affect supplemental information contained in our external disclosures including information regarding contingencies, risk and financial condition.  We believe our use of estimates and underlying accounting assumptions adhere to GAAP and are consistently and conservatively applied.  We base our estimates on historical experience and on various other assumptions that we believe to be reasonable under the circumstances.  Actual results may differ materially from these estimates under different assumptions or conditions. We continue to monitor significant estimates made during the preparation of our financial statements.
  14
  Our significant accounting policies are summarized in Note D of our financial statements.  While all these significant accounting policies impact our financial condition and results of operations, we view certain of these policies as critical. Policies determined to be critical are those policies that have the most significant impact on our financial statements and require management to use a greater degree of judgment and estimates.  Actual results may differ from those estimates. Our management believes that given current facts and circumstances, it is unlikely that applying any other reasonable judgments or estimate methodologies would cause effect on our consolidated results of operations, financial position or liquidity for the periods presented in this report.
 
 Item 3 - Quantitative and Qualitative Disclosures About Market Risk
 
 Not required of a smaller reporting company.
 
 Item 4 - Controls and Procedures
 
 (a) Evaluation of Disclosure Controls and Procedures
 
 Our management, under the supervision and with the participation of our Chief Executive and Chief Financial Officers (Certifying Officers), have evaluated the effectiveness of our disclosure controls and procedures as defined in Rules 13a-15 promulgated under the Exchange Act as of the end of the period covered by this Quarterly Report.  Disclosure controls and procedures are controls and procedures designed to ensure that information required to be disclosed in our reports filed or submitted under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the Commission’s rules and forms and include controls and procedures designed to ensure that information we are required to disclose in such reports is accumulated and communicated to management, including our Certifying Officers, as appropriate, to allow timely decisions regarding required disclosure.  Based upon that evaluation, our Certifying Officers have concluded that as of such date, our disclosure controls and procedures were not effective to ensure that the information required to be disclosed by us in our reports is recorded, processed, summarized and reported within the time periods specified by the SEC due to a inherent weakness in our internal controls over financial reporting due to our status as a shell corporation and having a sole supervising officer.  However, our Certifying Officers believe that the financial statements included in this report fairly present, in all material respects, our financial condition, results of operations and cash flows for the respective periods presented.
 
 (b) Changes in Internal Controls
 
 There were no other significant changes (including other corrective actions with regard to significant deficiencies or material weaknesses) in our internal controls over financial reporting that occurred during the quarter ended June 30, 2016 that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.
 
 Part II - Other Information
 
 Item 1 - Legal Proceedings
 
 None
 
 Item 1A – Risk Factors
 
 We are a smaller reporting company as defined by Reg. 240.12b-2 of the Securities Exchange Act of 1934 and are not required to provide the information under this item.
 
 Item 2 - Unregistered Sales of Equity Securities and Use of Proceeds
 
 None
 
 Item 3 - Defaults Upon Senior Securities
 
 None
 
 Item 4 - Mine Safety Disclosure
 
 N/A
 
 Item 5 - Other Information
 
 Effective March 31, 2016, the Company’s subsidiary, Medical Management Systems, Inc., terminated an outstanding Management Contract for the management and operation of three (3) marijuana dispensaries located in Bend, Newport and Cottage Grove, Oregon and wrote off all accrued management fees receivable (and the related deferred revenues) due to lack of performance on the part of the marijuana dispensaries as compared to the original projections and representations.
  15
  Effective March 31, 2016, the Company liquidated its Med-Pharma Management, Inc. and High Desert MMJ, Inc. subsidiaries.
 
 On February 29, 2016, the Company filed a Definitive Information Statement on Schedule 14C with the Securities and Exchange Commission noting a pending 1 for 10 reverse split of the Company’s issued and outstanding common stock; as approved by the Company’s Board of Directors, and a concurrent amendment to the Company’s Articles of Incorporation setting the authorized capital of the Company from the authorized, as adjusted, 25,000,000 post-split shares of common stock to 500,000,000 shares of $0.001 par value common stock and the authorized, as adjusted, 250,000 post-split shares of preferred stock to 25,000,000 shares of $0001 par value preferred stock.  This action is anticipated to take place during the 2nd quarter of Calendar 2016.
 
 On June 1, 2016, the Company entered into a Settlement, General and Mutual Release of Claims and Assignment of Interest Transfer Agreement (Settlement Agreement) with its majority shareholder and a related party.  The Settlement Agreement relates to the Company’s management of three medical marijuana dispensaries (Stores) located in Oregon, which are owned by Bendor Investments, Ltd. (Bendor), whose sole shareholder is Charles Stidham.  The Company owes Mr. Stidham approximately $1,100,000, including accrued interest, as of the date of the Settlement Agreement.
 
 The Company asserted a claim for management fees of approximately $80,000 and reimbursement of monies advanced to support the operations of the Stores totaling approximately $343,000 for the services of the Company’s wholly-owned subsidiary, Medical Management Systems, Inc. (MMS), in managing the Stores.  Bendor disputed this claim.  To resolve the dispute, the parties agreed to forgive the accrued management fees and to offset the approximately $343,000 due from Bendor against the approximately $1,100,000 owed to Mr. Stidham with the Company releasing any and all interests it may have had in the Stores and MMS.  Additionally, the Company agreed to assign a trademark to Mr. Stidham as well as executing a new Note in the principal sum of $752,694.19.
 
 Item 6 - Exhibits
 
 31.1
Certification pursuant to Section 302 of Sarbanes-Oxley Act of 2002 - Chief Executive and Financial Officer
 32.1
Certification pursuant to Section 906 of Sarbanes-Oxley Act of 2002 - Chief Executive and Financial Officer
 101
Interactive data files pursuant to Rule 405 of Regulation S-T. (+)
 
 (+) - to be filed separately by amendment
 
 SIGNATURES
 
 In accordance with the requirements of the Exchange Act, the registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
  MCPI, Inc.Dated: August 1, 2016

/s/ R.Wayne DukeR.Wayne DukeChief Executive and Financial Officer
  16